Table 2.
Serum and urine TRP-KYN metabolites between groups.
| Metabolites | Serum (ng/ml) | Urine (ng/ml) | ||||
|---|---|---|---|---|---|---|
| Patients (n = 38) | Controls (n = 43) | Z | Patients (n = 38) | Controls (n = 43) | Z | |
| TRP |
7946.68 (7283.19–9475.62) |
8324.27 (7218.98–9427.72) |
-0.48 |
12472.06 (6658.54–23027.40) |
15026.57 (8541.06–23352.03) |
-0.80 |
| KYN |
286.54 (219.91–425.20) |
349.23 (209.00–440.95) |
-0.69 |
710.39 (350.09–1228.97) |
550.90 (350.08–1092.33) |
-0.61 |
| KYNA |
0.14 (0.11–0.15) |
0.16 (0.12–0.18) |
-2.69** |
0.60 (0.31–1.29) |
0.79 (0.45–1.21) |
-1.07 |
| QUIN |
47.55 (43.94–50.68) |
47.55 (45.17–50.94) |
-0.13 |
3059.83 (1859.58–5183.54) |
3658.28 (2158.12–4712.76) |
-0.59 |
| PIC |
42.59 (32.76–54.64) |
38.65 (29.16–53.47) |
-0.60 |
162.38 (98.85–206.90) |
231.73 (148.28–291.00) |
-3.13** |
| XA |
2.84 (2.33–3.94) |
3.96 (2.98–5.34) |
-3.57** |
648.31 (344.32–1168.88) |
895.01 (508.05–1527.46) |
-1.16 |
| KYN/TRP |
0.04 (0.03–0.06) |
0.04 (0.03–0.05) |
-0.61 |
0.05 (0.04–0.06) |
0.04 (0.03–0.06) |
-2.77** |
| QUIN/KYN |
0.17 (0.12–0.21) |
0.14 (0.10–0.23) |
-0.73 |
4.15 (2.68–8.22) |
5.85 (3.24–8.74) |
-1.25 |
| KYNA/KYN |
0.0004 (0.0003–0.0006) |
0.0005 (0.0003–0.0007) |
-0.84 |
0.0008 (0.0004–0.0021) |
0.0014 (0.0007–0.0022) |
-1.66 |
| QUIN/KYNA |
346.88 (302.77–456.02) |
299.36 (269.04–366.78) |
-2.44* |
6547.52 (3027.95–10081.04) |
4294.33 (3248.22–7334.07) |
-0.90 |
| PIC/QUIN |
0.86 (0.71–1.12) |
0.76 (0.62–1.16) |
-0.73 |
0.04 (0.03–0.06) |
0.07 (0.04–0.09) |
-2.32* |
TRP-KYN metabolites are presented as median (IQR) and were compared between groups using the Mann-Whitney U test. TRP, tryptophan. KYN, kynurenine. KYNA, kynurenic acid. QUIN, quinolinic acid. PIC, picolinic acid. XA, xanthurenic acid. *p < 0.05. **p < 0.01.